AdvanDx Gets FDA OK for Faster Staphylococcus Dx

Molecular diagnostics firm AdvanDx said Thursday that it has received US Food and Drug Administration clearance for faster versions of its Staphylococcus aureus and S. aureus/coagulase-negative Staphylococci diagnostic tests.
GenomeWeb Daily News